CASE.EDU:    HOME | DIRECTORIES | SEARCH
case western reserve university

DEPT. OF EPIDEMIOLOGY
& BIOSTATISTICS

 

MENDEL E. SINGER, PH.D.


Assistant Professor
Division of Health Services Research and Policy

Director of Research,
Division of Public Health

Infectious diseases
Orthodox Jewish Health
Cost-Effectiveness Analysis

Office: School of Medicine, Wood Bldg. WG-51
Phone: (216) 368-1951
E-mail: mendel@case.edu
Education
Ph.D. 1991, Case Western Reserve University (Operations Research)
M.S. 1984, Case Western Reserve University (Operations Research)
B.A. 1981, Rutgers University (Mathematics)


Research Interests
Methodologic interests include cost-effectiveness analysis, large databases, quality of life and application of Public Health interventions to Orthodox Jewish communities. Disease areas of interest include infectious disease, with emphasis on respiratory tract infections and the impact of antibiotic resistance, as well as Hepatitis C and obesity.


Courses Taught
MPHP 405: Statistical Methods in Public Health
EPBI/MPHP 467: Cost-Effectiveness Analysis in Health Care
EPBI 461: Health Services Research Methods II


Professional Memberships
American Public Health Association
International Society for Pharmacoeconomics and Outcomes Research

Recent and Noted Publications
Singer ME. Cost-Effectiveness Analysis - Developing Nations Left Behind. PharmacoEconomics. 2008;26 (5):359-61.

Rose J, Singer ME. Projecting vaccine efficacy: accounting for geographic strain variations PharmacoEconomics. 2008;26(3): 185-189.

Dawson NV, Singer ME, Lenert L et al. Health State Valuation in Mild to Moderate Dementia: Feasibility of Computer-Based Ascertainment Techniques. Medical Decision Making. 2008; 28(2): 220-232.

Paladino JA, Sunderlin JL, Singer ME, Adelman MH, Schentag JJ. Observations on vancomycin use in U.S. hospitals. American Journal of Health-System Pharmacy. 2007; 64(15): 1633-41.

Del Rio RA, Post AB, Singer ME. Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy. Hepatology. 2006;44(6):1598-1606.

Singer ME, Harding I, Jacobs MR, Jaffe DH. Impact of antimicrobial resistance on health outcomes in the outpatient treatment of adult community-acquired pneumonia: a probability model. J Antimicrob Chemotherapy. 2003; 51, 1269-1282.

Barzilai DA, Singer ME. Potential impact of an intervention to reduce rates of insufficient excision margins for malignant melanoma. Journal of Investigative Dermatology. 2003;120(6): 1067-72.

Sehgal AR, Leon JB, Siminoff LA, Singer ME, Bunosky LM, Cebul RD. Improving the quality of hemodialysis treatment: a community-based randomized controlled trial to overcome patient specific barriers. JAMA. 2002;287(15):1961-7

Singer ME, Applegate KE. Cost-Effectiveness Analysis in Radiology. Radiology. 2001; 219: 611-620.

Singer ME, Younossi ZM. Cost-Effectiveness of screening for Hepatitis C Virus in Asymptomatic, Average Risk Adults: Has the Time Come? Am J Med. 2001; 111:614-621.

Scholarly Activities
Guest Editor, Special Issue, Cost-Effectiveness Analysis in Developing Nations, PharmacoEconomics.
Editorial Board, Pharmacoeconomics.


Last Updated: September 3, 2008